1-13 of 13
probit trial
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Evaluation of Efficacy and Safety of Front-Line Regimens for the Treatment of Transplant Ineligible Patients with Multiple Myeloma: A Network Meta-Analysis of Phase 2/3 Randomized Controlled Trials

Smith Giri, MBBS, Madan R Aryal, MD, Han Yu, PhD, Alyssa Grimshaw, MSLIS, Ranjan Pathak, MD, Scott F. Huntington, MD MPH, Binod Dhakal, MBBS
Journal: Blood
Blood (2019) 134 (Supplement_1): 2188.
https://doi.org/10.1182/blood-2019-130389
Published: 2019
Journal Articles

The Total Direct Cost of Healthcare in the United States in Patients with Sickle Cell Disease: A Propensity Score Matched Analysis

Jonathan Salcedo, MA, Colin M Young, PhD, Jenniffer Bulovic, MD MPH
Journal: Blood
Blood (2019) 134 (Supplement_1): 4671.
https://doi.org/10.1182/blood-2019-122597
Published: 2019
Journal Articles

Simultaneous Kinase Inhibition with Ibrutinib and BCL2 Inhibition with Venetoclax As a Therapeutic Strategy for Acute Lymphoblastic Leukemia

Christopher A. Eide, Stephen E Kurtz, PhD, Andy Kaempf, MS, Nicola Long, Jessica Leonard, MD, Bill H. Chang, MD PhD, Motomi Mori, PhD, Brian J. Druker, Jeffrey W. Tyner
Journal: Blood
Blood (2019) 134 (Supplement_1): 3950.
https://doi.org/10.1182/blood-2019-131288
Published: 2019
Journal Articles

Combining p38MAPK Inhibitors with a Second Targeted Agent Enhances Blockade of Inflammatory Signaling-Mediated Survival in Acute Myeloid Leukemia Cells

Stephen E Kurtz, PhD, Christopher A. Eide, Narain P. Dubey, Andy Kaempf, Shannon K. McWeeney, PhD, Cristina E. Tognon, PhD, Motomi Mori, PhD, Brian J. Druker, MD, Jeffrey W. Tyner, PhD, Anupriya Agarwal, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2726.
https://doi.org/10.1182/blood-2018-99-117537
Published: 2018
Journal Articles

RGL4 over Expression Correlates with Variation in Midostaurin Response in FLT3-ITD Mutant AML Samples

Mara Rosenberg, BS, Cristina E. Tognon, PhD, Kevin M Watanabe-Smith, PhD, Uma Borate, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1365.
https://doi.org/10.1182/blood-2018-99-120296
Published: 2018
Journal Articles

Genetics of Factor VIII Inhibitor Development in Hemophilia Patients: Novel Statistical Approaches in the PATH Study

Vincent P. Diego, PhD, Marcio A. Almeida, PhD, Bernadette W. Luu, BS, MT/CLS, Karin Haack, PhD, Meera B. Chitlur, MD, Afshin Ameri, MD, Long V. Dinh, PhD, Raja Rajalingam, PhD, Jerry S. Powell, MD, John Blangero, PhD, Laura Almasy, PhD, Shelley Cole, PhD, Tom E. Howard
Journal: Blood
Blood (2018) 132 (Supplement 1): 1199.
https://doi.org/10.1182/blood-2018-99-120021
Published: 2018
Journal Articles

Dual Inhibition of Bruton's Tyrosine Kinase and BCL2: A Promising Therapeutic Strategy for Myeloid and Lymphoid Leukemias

Christopher A. Eide, Stephen E Kurtz, PhD, Andy Kaempf, Cristina E. Tognon, PhD, Motomi Mori, PhD, Max J. Gordon, MD, Jeffrey W. Tyner, PhD, Alexey V Danilov, MD PhD, Brian J. Druker, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 214.
https://doi.org/10.1182/blood-2018-99-117468
Published: 2018
Journal Articles

Identification of Effective Combinations of Targeted Drugs for DNMT3A and NPM1 Mutated Acute Myeloid Leukemia

Stephen E Kurtz, PhD, Christopher A. Eide, Andy Kaempf, Samantha L Savage, Anna M. Reister Schultz, Beth Wilmot, PhD, Shannon Mcweeney, PhD, Motomi Mori, PhD, Elie Traer, MD PhD, Brian J. Druker, MD, Jeffrey W. Tyner, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2068.
https://doi.org/10.1182/blood.V130.Suppl_1.2068.2068
Published: 2017
Journal Articles

Differential Ex Vivo Sensitivity Patterns to Small-Molecule Inhibitors and Combination Therapies Among Acute Myeloid Leukemia Patients Harboring Both FLT3 and NPM1 Mutations

Christopher A. Eide, Stephen E Kurtz, PhD, Andy Kaempf, Andrew Park, Angela Rofelty, Beth Wilmot, PhD, Daniel Bottomly, Shannon K. McWeeney, PhD, Cristina E. Tognon, PhD, Motomi Mori, PhD, Jeffrey W. Tyner, PhD, Brian J. Druker, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1422.
https://doi.org/10.1182/blood.V130.Suppl_1.1422.1422
Published: 2017
Journal Articles

Identification of Effective Combinations of Targeted Drugs for Hematologic Malignancies

Stephen E Kurtz, PhD, Christopher A. Eide, Andy Kaempf, Vishesh Khanna, BS, Samantha L. Savage, Angela Rofelty, Isabel English, Hibery Ho, Motomi Mori, PhD, Elie Traer, MD, Brian J. Druker, MD, Jeffrey W. Tyner, PhD
Journal: Blood
Blood (2016) 128 (22): 836.
https://doi.org/10.1182/blood.V128.22.836.836
Published: 2016
Journal Articles

Gene Expression Profiling Reveals 5-Azacytidine to Be a Novel, Potentially Effective Therapy for Poor-Prognosis Patients with Multiple Myeloma.

Sascha Tuchman, MD, Chaitanya Acharya, William Mostertz, William Barry, PhD, Cristina Gasparetto, MD, Bart Barlogie, MD, PhD, Anil Potti, M.D., John D Shaughnessy, Jr., Ph.D.
Journal: Blood
Blood (2009) 114 (22): 1833.
https://doi.org/10.1182/blood.V114.22.1833.1833
Published: 2009
Journal Articles

Quantitative Phenotyping and Discriminant Analysis Improve Scoring Classification in Late B-Lymphoproliferative Disorders.

Georges Jung, Sylvie Thiebault, Jean-Claude Eisenmann, Eckart Wunder, Marie Haas, Yasid Arkam, Mario Ojeda-Uribe, Philippe Henon
Journal: Blood
Blood (2005) 106 (11): 1463.
https://doi.org/10.1182/blood.V106.11.1463.1463
Published: 2005
Journal Articles

Patient Preferences for Treatment Products in Hemophilia: A Conjoint Analysis (Conan Study Group).

Alessandro Gringeri, MD, MSc, Piermannuccio Mannucci, MD, Mara Monzini, PharmD, Luciana Scalone, PharmD, Lorenzo Mantovani, MSc, DSc
Journal: Blood
Blood (2004) 104 (11): 2203.
https://doi.org/10.1182/blood.V104.11.2203.2203
Published: 2004